2-(2',3',4'-TRIHYDROXYBUTYL)QUINOXALINE
- $105 - $1355
- Product name: 2-(2',3',4'-TRIHYDROXYBUTYL)QUINOXALINE
- CAS: 42015-38-3
- MF: C12H14N2O3
- MW: 234.25
- EINECS:
- MDL Number:MFCD07369681
- Synonyms:2-(2',3',4'-TRIHYDROXYBUTYL)QUINOXALINE;4-(2-quinoxalinyl)-;1,2,3-Butanetriol, 4-(2-quinoxalinyl)-
3 prices
Selected condition:
Brand
- American Custom Chemicals Corporation
- TRC
Package
- 5MG
- 100mg
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberMTB0001975
- Product description2-(2',3',4'-TRIHYDROXYBUTYL)QUINOXALINE 95.00%
- Packaging5MG
- Price$505.57
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberT795050
- Product description2-(2’,3’,4’-Trihydroxybutyl)quinoxaline
- Packaging5mg
- Price$105
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberT795050
- Product description2-(2’,3’,4’-Trihydroxybutyl)quinoxaline
- Packaging100mg
- Price$1355
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
American Custom Chemicals Corporation | MTB0001975 | 2-(2',3',4'-TRIHYDROXYBUTYL)QUINOXALINE 95.00% | 5MG | $505.57 | 2021-12-16 | Buy |
TRC | T795050 | 2-(2’,3’,4’-Trihydroxybutyl)quinoxaline | 5mg | $105 | 2021-12-16 | Buy |
TRC | T795050 | 2-(2’,3’,4’-Trihydroxybutyl)quinoxaline | 100mg | $1355 | 2021-12-16 | Buy |
Properties
Melting point :108-109°C
Boiling point :520.4±50.0 °C(Predicted)
Density :1.385±0.06 g/cm3(Predicted)
storage temp. :Hygroscopic, -20°C Freezer, Under Inert Atmosphere
solubility :DMSO (Slightly), Methanol (Slightly, Heated)
form :Solid
pka :13.59±0.20(Predicted)
color :Off-White to Beige
Boiling point :520.4±50.0 °C(Predicted)
Density :1.385±0.06 g/cm3(Predicted)
storage temp. :Hygroscopic, -20°C Freezer, Under Inert Atmosphere
solubility :DMSO (Slightly), Methanol (Slightly, Heated)
form :Solid
pka :13.59±0.20(Predicted)
color :Off-White to Beige
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|